Lv67
2350 积分 2022-09-22 加入
洞察前沿 放眼国际：2023年美国风湿病学会学术年会收获
18天前
已关闭
B cell dysregulation and depletion therapy in primary membranous nephropathy: Prospects and potential challenges
1个月前
已完结
Membranous nephropathy: new pathogenic mechanisms and their clinical implications
1个月前
已完结
Demographic distribution analysis of different glomerular diseases in Southwest China from 2008 to 2022
1个月前
已完结
Evaluation of belimumab in treatment of Chinese childhood-onset systemic lupus erythematosus: a prospective analysis from a multicentre study
1个月前
已完结
Type I interferon blockade with anifrolumab in patients with systemic lupus erythematosus modulates key immunopathological pathways in a gene expression and proteomic analysis of two phase 3 trials
1个月前
已完结
Association of Modified Systemic Lupus Erythematosus Responder Index Attainment With Long-Term Clinical Outcomes: A Five-Year Prospective Study
2个月前
已完结
Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study
2个月前
已完结
Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study
3个月前
已关闭
皖公网安备34019202002308
